Platform
Ricovr’s P-FAB platform uses a U-bent optical fiber to amplify interactions between light and target biomarkers in saliva samples.
ricovr.comCrawled Oct 15, 2026
Ricovr’s P-FAB platform uses a U-bent optical fiber to amplify interactions between light and target biomarkers in saliva samples.
Saliva testing is the best method for detecting recent use of (THC) marijuana.
A conversation with HR leader Brett Felmey to discuss how the increase in access and legalization of cannabis has affected the workplace.
The post explains how long THC remains in the body and discusses oral fluid testing for recent cannabis use.
The latest news on marijuana legalization, workplace & public safety, drug testing, and XALIVA THC.
The page discusses saliva-based testing for marijuana (THC) and a study on its utility and detection capabilities.
The article states that more than 50 million urine-based drug tests for marijuana are conducted annually and says urine tests have been endorsed by the Federal Government.
Ricovr Healthcare received an NIH grant to develop XALIVA, a screening device for point-of-care THC detection.
RICOVR Healthcare is hiring a firmware engineer to work on its rapid diagnostics testing platform.
RICOVR Healthcare is hiring a QA/RA lead with project management skills for its rapid diagnostics testing platform.
RICOVR Healthcare is hiring an R&D Integration and Test Engineer.
Ricovr’s saliva-based platform provides point-of-need diagnostics and uses fiber optics to detect biomarkers. Its THC test for workplace safety is described as a foundation for expansion into other health markets.
Ricovr’s privacy policy describes how Ricovr collects, uses, and shares personal data.
Ricovr Healthcare has received an NIH grant to advance **XALIVA®**, a point-of-care device for accurate **THC detection**. The screening tool aims to provide rapid, on-site testing capabilities for healthcare providers.
Ricovr Healthcare presents at the **GEC+ Puerto Rico** event, highlighting its **Xaliva THC device**, a cannabis testing solution. The company’s technology aims to streamline potency and safety verification for cannabis products. The presentation underscores Ricovr’s focus on advancing regulatory compliance in the cannabis industry.
Ricovr Healthcare wins the **IAM Civil Rights Trailblazer Award** for advancing fairness and equity in healthcare. The company’s work focuses on removing systemic barriers in patient access and treatment. The award recognizes its leadership in promoting inclusive healthcare practices.
Ricovr Healthcare appoints Pratik Patel as Chief Marketing Officer to drive the launch and scaling of its **XALIVA® THC device solution**, targeting improvements in employer-based drug testing. The move aims to expand market reach and adoption of the company’s testing technology.
Jo McGuire, a recognized expert in drug testing, has joined Ricovr Healthcare as a strategic advisor. Her experience in the field supports Ricovr’s focus on improving healthcare diagnostics. The appointment aims to strengthen Ricovr’s advisory capabilities in drug development and testing.

RICOVR offers a portable, non-invasive testing platform using nanoparticle detection for quick and versatile diagnostics.